drugset / Trial / NCT02367846

Assessing the Impact of Contraceptives on Bone Health Using 41Ca

NCT02367846

Phase 4 Active not recruiting 6 enrolled Penn State University Purdue University · collab
RandomizedCrossoverOpen-labelBasic science

Summary

This preclinical randomized crossover study will examine the effects of oral versus non-oral contraceptive therapy on bone turnover in young exercising women. In an effort to expose the route-dependent effects of oral versus non-oral contraceptive therapy on bone turnover, the investigators will examine 1) the effects of ethinyl estradiol on bone calcium balance using the 41Ca technology and 2) the underlying physiological mechanisms associated with the effects of oral versus non-oral contraceptive therapy on net bone calcium balance.

Timeline

Start
2015-01
Primary completion
2028-12
Completion
2028-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Desogestrel Small molecule 150 ug Oral
Subject Etonogestrel Unknown 120 ug Other
Subject ethinyl estradiol Small molecule 15 ug Oral
Subject ethinyl estradiol Small molecule 30 ug Oral